Diagnosis and Treatment of Parkinson Disease: A Review.

@article{Armstrong2020DiagnosisAT,
  title={Diagnosis and Treatment of Parkinson Disease: A Review.},
  author={Melissa J. Armstrong and Michael S. Okun},
  journal={JAMA},
  year={2020},
  volume={323 6},
  pages={
          548-560
        }
}
Importance Parkinson disease is the most common form of parkinsonism, a group of neurological disorders with Parkinson disease-like movement problems such as rigidity, slowness, and tremor. More than 6 million individuals worldwide have Parkinson disease. Observations Diagnosis of Parkinson disease is based on history and examination. History can include prodromal features (eg, rapid eye movement sleep behavior disorder, hyposmia, constipation), characteristic movement difficulty (eg, tremor… 
An Update on Medical and Surgical Treatments of Parkinson’s Disease
TLDR
The diagnosis of PD is mainly clinical, but dopamine transporter single-photon emission computed tomography can improve the accuracy of the diagnosis, and dopamine based therapies are used for the treatment of motor symptoms.
Parkinson's disease
Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini Review
TLDR
The need for a more unified approach in managing these “orphan” symptoms, from the very beginning of the disease, is highlighted and the concept "the sooner the better” should be applied to multidisciplinary non-pharmacological management in PD.
Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
  • F. Church
  • Psychology, Medicine
    Biomolecules
  • 2021
TLDR
The best strategy for treating PD is to hope to slow disorder progression and strive to achieve stability with neuroprotection, an integrative medicine and health strategy that highlights five treatment options for people with Parkinson’s.
Parkinson’s disease: etiopathogenesis and treatment
  • J. Jankovic, E. Tan
  • Biology, Psychology
    Journal of Neurology, Neurosurgery, and Psychiatry
  • 2020
TLDR
The involvement of dopaminergic as well as noradrenergic, glutamatergic, serotonergic and adenosine pathways provide insights into the rich and variable clinical phenomenology associated with PD and the possibility of alternative therapeutic approaches beyond traditional dopamine replacement therapies.
The role of neuroimaging in Parkinson’s disease
TLDR
This review addresses the application of functional MRI, PET, and SPECT in PD patients and provides an overview of the imaging targets, the rationale behind target selection, the agents (tracers) with which the imaging can be performed, and the main findings regarding each target's state in PD.
Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review
TLDR
Istradefylline, a novel adenosine A2A receptor antagonist, is indicated as a treatment addition to levodopa/carbidopa in patients experiencing “off episodes” of Parkinson’s disease.
Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
TLDR
It is shown for the first time that neuronal loss in LC contributes to dyskinesia in advanced PD patients, while neither Lewy body scores in SN nor LC had significant effects.
Cognitive and Behavior Deficits in Parkinson's Disease with Alteration of FDG-PET Irrespective of Age.
TLDR
Two particular cases of PD are reported in which the assessment of brain metabolic activity (from FDG-PET) has been combined with clinical aspects of non-motor symptoms, allowing us to improve the treatment of PD patients irrespective of age.
Therapies for Genetic Forms of Parkinson’s Disease: Systematic Literature Review
TLDR
An improvement of therapeutic options for PD is warranted including a treatabolome database to guide clinicians in treatment decisions, and novel disease-cause-modifying drugs are needed.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 75 REFERENCES
Parkinson’s Disease: Pathogenesis and Clinical Aspects
TLDR
This book integrates the considerable expertise of a range of authors from different disciplines, from clinicians through to basic scientists, to present a comprehensive and up-to-date overview of Parkinson’s disease.
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
TLDR
Parkinson clinical subtypes at diagnosis may estimate disease course and survival, which may be useful in providing a more accurate prognosis in individual patients in clinical practice and helping to stratify subgroups in clinical trials.
Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study
TLDR
Evaluated prevalence and progression of these three types of tremor in early stages of the disease, and investigated longitudinally the relationship between dopaminergic and serotonergic terminal dysfunction, rest tremor severity and its response to dopaminaergic therapy.
Parkinson disease subtypes.
TLDR
To evaluate available evidence, based on findings from clinical, imaging, genetic and pathologic studies, supporting the differentiation of Parkinson disease into subtypes, a systematic review of articles cited in PubMed between 1980 and 2013 is performed.
A clinicopathologic study of 100 cases of Parkinson's disease.
TLDR
The clinical details of 100 cases of histologically confirmed Parkinson's disease were examined and correlated with pathologic findings, finding the general pattern of disease conformed to traditional descriptions, and the findings broaden the present clinical and pathologic spectrum of Parkinson's Disease.
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
TLDR
Four novel clusters are found that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates, which has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials.
MDS clinical diagnostic criteria for Parkinson's disease
  • R. Postuma, D. Berg, G. Deuschl
  • Psychology, Medicine
    Movement disorders : official journal of the Movement Disorder Society
  • 2015
TLDR
The Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity, and two levels of certainty are delineated: clinically established PD and probable PD.
Non-motor features of Parkinson disease
TLDR
Recent advances that have helped to establish the presence, severity and effect on the quality of life of non-motor symptoms in PD are discussed, and the neuroanatomical and neuropharmacological mechanisms involved are discussed.
Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression?
TLDR
This review aims to summarize the most valid conventional and recent subtyping solutions that have been introduced so far and to update current knowledge with recent discoveries on the association between subtypes and disease progression.
Drooling in Parkinson's disease: a review.
...
1
2
3
4
5
...